1-3 of 3
Pino Poddighe
Close
Sort by
Journal Articles

Prognostic Relevance of Cytogenetic Chromosomal Abnormalities on Outcome Among AL Amyloidosis Patients in the Netherlands

Leonie Abbink, Mirian Brink, Wilfried Roeloffzen, Pino Poddighe, Monique C. Minnema
Journal: Blood
Blood (2021) 138 (Supplement 1): 2703.
https://doi.org/10.1182/blood-2021-152099
Published: 2021
Journal Articles

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial

Sonja Zweegman, MDPhD, Fredrik H. Schjesvold, MDPhD, Bronno van der Holt, PhD, Mark-David Levin, MDPhD, Claudia A.M. Stege, MD, Anders Waage, MD PhD, Maria B.L. Leijs, MD, Saskia K. Klein, MDPhD, Damian L. Szatkowski, MDPhDMSc, Per Axelsson, MD, Trung Hieu Do, MD, Dorota Knut-Bojanovska, Ellen van der Spek, MDPhD, Asta Svirskaite, Pino Poddighe, MDPhD, Marian Stevens-Kroef, MD, Markus Hansson, MD PhD, Niels WCJ van de Donk, MD PhD, Einar Haukas, MD, Pieter Sonneveld, MDPhD, Niels Abildgaard, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 800.
https://doi.org/10.1182/blood-2018-99-111650
Published: 2018
Journal Articles

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies

Brief Report
Arjan Buijs, Pino Poddighe, Richard van Wijk, Wouter van Solinge, Eric Borst, Leo Verdonck, Anton Hagenbeek, Peter Pearson, Henk Lokhorst
Journal: Blood
Blood (2001) 98 (9): 2856–2858.
https://doi.org/10.1182/blood.V98.9.2856
Published: 2001